Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.25.4
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
REVENUE $ 150,000 $ 100,000
OPERATING EXPENSES:    
Costs of revenue 42,000 28,000
Professional fees and related costs 788,000 959,000
General and administrative 2,485,000 2,614,000
Amortization of patents 141,000 120,000
TOTAL OPERATING EXPENSES 3,456,000 3,721,000
OPERATING LOSS (3,306,000) (3,621,000)
  OTHER INCOME    
Interest and dividend income, net 1,844,000 1,897,000
Net realized and unrealized gain on marketable securities 277,000 177,000
Total other income, net 2,121,000 2,074,000
LOSS BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE (1,185,000) (1,547,000)
INCOME TAXES PROVISION:    
Current (31,000)
Deferred taxes, net (337,000) (425,000)
Total income taxes benefit (368,000) (425,000)
  LOSS BEFORE SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE: (817,000) (1,122,000)
SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE (1,603,000) (1,912,000)
  NET LOSS $ (2,420,000) $ (3,034,000)
Net Loss Per Share:    
Basic $ (0.11) $ (0.13)
Diluted $ (0.11) $ (0.13)
Weighted average common shares outstanding:    
Basic 22,848,402 23,250,224
Diluted 22,848,402 23,250,224
  Cash dividends declared per share $ 0.10 $ 0.10